Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
TrioTech Unveils Cutting-Edge Innovations at Press Conference | Siew Wai Yong, CEO AT Trio-Tech International
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Trio-Tech International's CEO is Siew Yong
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Dolby Laboratories' President and CEO Kevin Yeaman, alongside San Francisco Mayor Edwin Lee, formally inaugurated Dolby's new headquarters.|Dolby Laboratories President and Chief Executive Officer Kevin Yeaman
00:10:00
Athanasios Papanikolaou and Vivartia's Agri-Food Leadership Part-2 | Athanasios Papanikolaou, CEO, Marfin Investment Group.
00:10:00
John Young Discusses Aphrodite Gold Deposit and Strategic Plans
00:10:00
Interview with Massimo Mauri, CEO of SECO.
00:10:00
Empowering Communities Through Financial Health and Workforce Development
00:10:00
Michael Joyce’s Summer 2024 Market Outlook | Michael Joyce, President , Agili .
00:10:00
Watch CEO Chris Bursey's complete OTCQXVideo interview as Remark Holdings, Inc. is welcomed with enthusiasm.
00:10:00
Uncovering Offshore Funds: Insights on Tax Reform and Transparency - Ricardo Martner, Commissioner at ICRICT
00:10:00
working in the digital redesign of the everyday economy|David Beisel,Co-Founder and Partner,NextView Ventures
00:10:00
Exploring Potential: Casino Resources' Nickel-Copper Project at One-to-One Mining Conference in London
00:10:00
The benefits for startups to raise funds from celebrity investors such as American actor|Keisuke Honda,Co-Founder,Dreamers VC
00:10:00
Building Relationships and Elevating Communication: Insights from Mark Barragan | Estrada Strategies Interview